Search

Tortilla Market Expected to Reach $80.03 Billion by 2035

The global tortilla market is on a growth trajectory, with the market size reaching USD 47.75 billion in 2025. It is projected to rise from USD 50.28 billion in 2026 to approximately USD 80.03 billion by 2035, registering a CAGR of 5.3% during the forecast period from 2026 to 2035.

This growth is largely driven by the rising consumer demand for ready-to-eat and convenient food products, as tortillas increasingly feature in everyday diets worldwide. The market expansion reflects shifting lifestyles, urbanization, and the growing preference for quick, versatile, and nutritious meal options.

Industry stakeholders are expected to leverage this growth by innovating with flavored, whole grain, and specialty tortillas to cater to evolving consumer tastes and preferences.

Acai Berry Market Set to Reach $3.28 Billion by 2035

The global acai berry market is witnessing steady growth, with the market size estimated at USD 1.65 billion in 2025. It is projected to expand to USD 1.77 billion in 2026 and reach nearly USD 3.28 billion by 2035, registering a CAGR of 7.1% during the forecast period from 2026 to 2035.

The growth is driven primarily by the rising popularity of acai berries as a superfood, alongside increasing consumer demand for dietary supplements and cosmetic products enriched with natural antioxidants. The market’s expansion reflects a broader trend toward health-conscious lifestyles and natural product adoption globally.

As acai continues to gain traction in functional foods, beverages, and personal care products, industry players are expected to capitalize on this lucrative growth opportunity in both emerging and established markets.

Global Protein Supplements Market to Reach USD 70.24 Billion by 2035

The global protein supplements market is projected to grow from an estimated USD 30.22 billion in 2025 to USD 32.88 billion in 2026, eventually reaching approximately USD 70.24 billion by 2035, reflecting a CAGR of 8.8% during the forecast period from 2026 to 2035.

Market expansion is fueled by the rising health and fitness trend and the growing demand for sports nutrition products. Consumers are increasingly focusing on protein intake to support muscle building, weight management, and overall wellness, driving the adoption of supplements across various age groups.

Key market trends include:
Increasing popularity of plant-based and vegan protein supplements
Expansion of ready-to-drink and convenient protein products
Rising awareness about nutritional supplementation among athletes and fitness enthusiasts

With the continued emphasis on healthy lifestyles and performance nutrition, the protein supplements market is poised for robust growth, presenting opportunities for manufacturers, retailers, and investors worldwide.

Global Soluble Corn Fiber Market to Reach USD 83.18 Billion by 2035

The global soluble corn fiber market was valued at USD 52.55 billion in 2025 and is projected to grow from USD 52.02 billion in 2026 to approximately USD 83.18 billion by 2035, registering a CAGR of 4.7% during the forecast period from 2026 to 2035.

Market growth is primarily driven by rising consumer awareness of digestive wellness, along with increasing demand for functional food ingredients that support gut health. Soluble corn fiber is widely used in food, beverages, and dietary supplements due to its prebiotic benefits, low-calorie profile, and clean-label appeal.

Key trends shaping the market include:
Growing use of fiber-enriched products in food and beverages
Rising preference for digestive health solutions
Expanding applications in nutritional supplements and functional foods

With continued focus on gut health and wellness, the soluble corn fiber market is expected to witness steady global expansion, offering significant opportunities for industry stakeholders.

Peptide and Heparin Market Size to Reach USD 58.9 Billion by 2031 | Growth Insights

Global peptide and heparin market is undergoing steady and strategic expansion, supported by rising demand for advanced biologic therapies and critical anticoagulation treatments. Valued at USD 42.5 billion in 2024, the market is projected to reach USD 58.9 billion by 2031, growing at a CAGR of 4.8% during the forecast period. This growth reflects the increasing clinical reliance on peptide-based drugs and heparin across cardiovascular care, oncology, and metabolic disorder management worldwide.

Access the complete report https://www.24lifesciences.com/peptide-and-heparin-market-9010

What Is the Future of the Global Glycoprotein Market? Growth Forecasts & Insights (2025–2031)

Global glycoprotein market is witnessing steady and resilient growth as glycosylated proteins continue to play a critical role in modern biomedical research and advanced biologic therapies. Valued at USD 462 million in 2024, the market is projected to reach USD 587 million by 2031, expanding at a compound annual growth rate (CAGR) of 3.6% over the forecast period. This growth trajectory reflects sustained investments in biologics, rising demand for high-precision therapeutic agents, and the expanding importance of glycosylation in drug safety, efficacy, and stability.

Access the complete report https://www.24lifesciences.com/glycoprotein-market-6869

What Is the Future of the Global Glycoprotein Market? Growth Forecasts & Insights (2025–2031)

Global glycoprotein market is witnessing steady and resilient growth as glycosylated proteins continue to play a critical role in modern biomedical research and advanced biologic therapies. Valued at USD 462 million in 2024, the market is projected to reach USD 587 million by 2031, expanding at a compound annual growth rate (CAGR) of 3.6% over the forecast period. This growth trajectory reflects sustained investments in biologics, rising demand for high-precision therapeutic agents, and the expanding importance of glycosylation in drug safety, efficacy, and stability.

Access the complete report https://www.24lifesciences.com/glycoprotein-market-6869

Global Rapid Diagnostics Market Expands as Point-of-Care Testing Becomes Central to Healthcare

Global rapid diagnostics market is witnessing robust expansion as healthcare systems worldwide prioritize early detection, faster clinical decisions, and decentralized testing models. Valued at approximately USD 46.7 billion in 2024, the market is projected to grow from USD 50.1 billion in 2025 to around USD 76.4 billion by 2032, registering a CAGR of 6.2% during the forecast period. This growth reflects the increasing reliance on rapid diagnostic solutions across hospitals, clinics, and community settings to improve patient outcomes and optimize healthcare efficiency.

Access the complete report https://www.24lifesciences.com/rapid-diagnostics-market-9182

What Is the Future of the Amoxicillin Clavulanate Potassium API Market? Growth Forecasts & Insights (2025–2031)

The global Amoxicillin Clavulanate Potassium API market is demonstrating steady expansion as healthcare systems continue to rely on broad-spectrum antibiotics to combat bacterial infections and antimicrobial resistance. Valued at USD 275 million in 2024, the market is projected to reach USD 415 million by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. This growth reflects sustained global demand for high-quality antibiotic active pharmaceutical ingredients (APIs), alongside evolving formulation strategies designed to improve efficacy against resistant pathogens.

Access the complete report https://www.24lifesciences.com/amoxicillin-clavulanate-potassium-api-market-8769

Global GIST Market Shows Steady Expansion Driven by Targeted Oncology Therapies

Global gastrointestinal stromal tumor (GIST) market is demonstrating sustained growth as advances in molecular oncology and targeted therapies continue to redefine treatment standards. Valued at USD 1.08 billion in 2024, the market is projected to grow from USD 1.15 billion in 2025 to USD 1.76 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. This upward trajectory reflects increasing diagnostic accuracy, wider access to tyrosine kinase inhibitors, and a growing emphasis on personalized cancer care worldwide.

Access the complete report https://www.24lifesciences.com/gastrointestinal-stromal-tumor-market-9149